Drug companies vow to work more closely with governments to combat antimicrobial resistanceBMJ 2016; 352 doi: https://doi.org/10.1136/bmj.i410 (Published 22 January 2016) Cite this as: BMJ 2016;352:i410
- Deborah Kirkham
- 1The BMJ
More than 80 international drug companies and key industry associations have issued a joint statement setting out how governments and industry can collaborate to overcome the growing threat of antimicrobial resistance, with a declaration launched at the World Economic Forum in Davos, Switzerland.
In the Declaration on Combating Antimicrobial Resistance commercial drug and diagnostic developers have agreed a common set of principles to support antibiotic conservation and the development of new drugs, diagnostic tests, and vaccines.1
Sally Davies, England’s chief medical officer, said, …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial